Work

159eP Prognostic value of the immune checkpoint inhibitor score (IChIS) in palliative immunotherapy-treated non-small cell lung cancer: A real-world study

Year: 2026

Type: article

Abstract: Identifying reliable prognostic biomarkers remains a major challenge in patients with advanced non-small cell lung cancer (NSCLC) receiving palliative immunotherapy. The immune checkpoint inhibitor score (IChIS), derived from systemic inflammatory parameters, may reflect host immune status; however, its real-world prognostic value is not well established.

Source: ESMO Open

DOI: 10.1016/j.esmoop.2026.106466